LONDON - As West Africa's devastating Ebola outbreak begins to dwindle, scientists are looking beyond the endgame at the kind of next-generation vaccines needed for a vital stockpile to hit another epidemic hard and fast.
LONDON, - Campaigners urged British lawmakers on Sunday to seize a chance to become the first in the world to allow three-way fertility treatments to families who want to avoid passing on incurable diseases to their children.
LONDON - Motif Bio, which is working on a range of antibiotics, is planning to raise at least 4 million pounds ($6 million) - and potentially up to 16 million - through a stock market listing in London.
BEIJING - China has listed food safety and modernizing farms as among key priorities this year, its 2015 rural policy outline showed, as it tackles falling agricultural productivity that has raised concerns about its future food supply.
LONDON - A British military healthcare worker was flown back to England from Sierra Leone on Saturday following a needle-stick injury sustained while treating a person with Ebola, the Public Health England (PHE) service said on Saturday.
WASHINGTON - The Obama administration on Friday proposed a plan to move most doctors, hospitals and their patients to national standards for handling electronic clinical data by the end of 2017.
SACRAMENTO, Calif. - Two patients hospitalized in Sacramento, California, and tested for possible Ebola infection were found to be free of the deadly virus within hours of each other on Friday.
WASHINGTON - The U.S. Food and Drug Administration on Friday approved Shire Plc's stimulant Vyvanse to treat binge-eating disorder, the first product to be approved for the condition.
LOS ANGELES - More than 100 people in the United States have been confirmed as infected with measles including 91 in California, most of them linked to an outbreak that began at Disneyland in December, public health officials said on Friday.
WASHINGTON - India's Sun Pharmaceutical Industries Ltd has won U.S. approval to buy Ranbaxy Laboratories Ltd on condition that it sell its interest in a generic antibacterial medicine, the U.S. Federal Trade Commission said on Friday.